Atlas Trials

Ocular Therapeutix, Inc.

33 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ocular Therapeutix, Inc.

RecordFirmDate
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study (NCT07516132)Ocular Therapeutix, Inc.2026-04-27
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration (NCT06495918)Ocular Therapeutix, Inc.2024-11-27
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration (NCT06223958)Ocular Therapeutix, Inc.2024-01-29
Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NCT05695417)Ocular Therapeutix, Inc.2023-01-15
An Observational, Qualitative Study Assessing Eye Drop Administration (NCT05307081)Ocular Therapeutix, Inc.2022-04-21
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) (NCT05335122)Ocular Therapeutix, Inc.2022-03-16
Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration (NCT04989699)Ocular Therapeutix, Inc.2021-07-28
A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects (NCT04945824)Ocular Therapeutix, Inc.2021-06-01
To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease (NCT04747977)Ocular Therapeutix, Inc.2021-02-12
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract (NCT04539548)Ocular Therapeutix, Inc.2020-09-04
A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis (NCT04050865)Ocular Therapeutix, Inc.2019-08-05
CLN-0046: Treatment of AMD Subjects With OTX-TKI (NCT03630315)Ocular Therapeutix, Inc.2019-02-18
A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert (NCT04061044)Ocular Therapeutix, Inc.2018-07-10
CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension (NCT04360174)Ocular Therapeutix, Inc.2018-04-25

Track Ocular Therapeutix, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.